TY - JOUR AU - Malikova, Hana PY - 2019 TI - Nephrogenic systemic fibrosis: the end of the story? JF - Quantitative Imaging in Medicine and Surgery; Vol 9, No 8 (August 27, 2019): Quantitative Imaging in Medicine and Surgery Y2 - 2019 KW - N2 - Gadolinium-based contrast agents (GBCA) have been standardly intravenously applied to improve visibility of MRI examinations since 1988, when gadopentetate dimeglumine (Magnevist ® ) was approved for clinical practice. Gadolinium itself is a heavy metal, highly toxic in biological systems. Therefore, gadolinium must be bound to ligands for the purpose of contrast agents. UR - https://qims.amegroups.org/article/view/27779